Literature DB >> 30325012

Physical Activity and Association Between Frailty and All-Cause and Cardiovascular Mortality in Older Adults: Population-Based Prospective Cohort Study.

Sara Higueras-Fresnillo1, Verónica Cabanas-Sánchez1, Esther Lopez-Garcia2,3, Irene Esteban-Cornejo4,5, José R Banegas2, Kabir P Sadarangani6,7, Fernando Rodríguez-Artalejo2,3, David Martinez-Gomez1,3.   

Abstract

OBJECTIVES: To examine the separate and joint association between physical activity and frailty and long-term all-cause and cardiovascular disease (CVD) mortality in older adults.
DESIGN: Population-based prospective cohort study.
SETTING: Cohort representative of the noninstitutionalized Spanish population. PARTICIPANTS: Individuals aged 60 and older (N=3,896) in 2000-01. MEASUREMENTS: Participants reported their physical activity using a validated instrument, and frailty was ascertained using the Fatigue, low Resistance, limitation in Ambulation, Illness and weight Loss (FRAIL) scale. Those with 0 frailty criteria were considered to be robust, with 1 or 2 criteria to be prefrail, and with 3 of more criteria to be frail. Participants were followed until 2014 to identify all-cause and CVD deaths. Associations were summarized using hazard ratios (HRs) and Cox regression after adjustment for main covariates.
RESULTS: During a median 14 years of follow-up, 1,801 total deaths occurred, 672 from CVD. Compared with being robust, the multivariate hazard ratio (95% confidence interval) for all-cause mortality was 1.29 (1.14-1.45) in prefrail individuals, and 2.16 (1.82-2.58) in frail individuals (p-trend <.001). Compared with being physically inactive, being physically active was associated with a statistically significant 18% (1-32%), 28% (16-39%) and 39% (17-55%) lower all-cause mortality among robust, prefrail, and frail individuals, respectively (all p <.001). Compared with participants who were robust and physically active, those who were frail and inactive showed the highest all-cause mortality 2.45 (95%CI: 1.95-3.06); however, the hazard ratio (95% confidence interval) for all-cause mortality in frail individuals who were physically active was comparable to that in pre-frail and inactive participants: 1.70 (1.32-2.19) and 1.56 (1.34-1.82), respectively. Mortality of prefrail active participants was similar to that of robust inactive participants. Results were similar for CVD mortality.
CONCLUSION: Physical activity might partly compensate for the greater mortality risk associated with frailty in old age. J Am Geriatr Soc 66:2097-2103, 2018.
© 2018, Copyright the Authors Journal compilation © 2018, The American Geriatrics Society.

Entities:  

Keywords:  elderly; frailty; mortality; physical activity

Mesh:

Year:  2018        PMID: 30325012     DOI: 10.1111/jgs.15542

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  15 in total

Review 1.  Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?

Authors:  Niharika A Duggal; Grace Niemiro; Stephen D R Harridge; Richard J Simpson; Janet M Lord
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

Review 2.  Isometric Exercise Training: A Review of Hypothesized Mechanisms and Protocol Application in Persons with Hypertension.

Authors:  Jacquelyn J Rickson; Stephen A Maris; Samuel A E Headley
Journal:  Int J Exerc Sci       Date:  2021-11-01

3.  Role of the N6-methyladenosine regulatory factor in reducing the risk of cardiovascular disease: subtype diagnosis following aerobic exercise-assisted weight loss.

Authors:  Xiaoya Hao; Yukun Li; Guo Huang; Ying Zeng
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

4.  Effect of moderate-intensity seated exercise on the management of metabolic outcomes in hypertensive individuals with or without exercise habits.

Authors:  Hiroto Honda; Makoto Igaki; Motoaki Komatsu; Shin-Ichiro Tanaka
Journal:  J Exerc Sci Fit       Date:  2020-10-05       Impact factor: 3.103

Review 5.  Cardiac Rehabilitation in Older Adults with Heart Failure: Fitting a Square Peg in a Round Hole.

Authors:  Kelsey M Flint; Amy M Pastva; Gordon R Reeves
Journal:  Clin Geriatr Med       Date:  2019-07-03       Impact factor: 3.076

6.  Associations of Frailty and Physical Function with a Daily Activities Measured by a Pattern-Recognition Activity Monitor: An Isotemporal Substitution Analysis in the IMPACT65+ Study.

Authors:  S Higueras-Fresnillo; M Á de la Cámara; V Cabanas-Sánchez; D Martínez-Gómez
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

7.  Associations of total and aerobic steps with the prevalence and incidence of frailty in older adults with hypertension.

Authors:  Elizabeth C Lefferts; Esmée A Bakker; Salvatore Carbone; Carl J Lavie; Duck-Chul Lee
Journal:  Prog Cardiovasc Dis       Date:  2021-02-26       Impact factor: 11.278

8.  Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study.

Authors:  Yu Jia; Dongze Li; Jing Yu; Yi Liu; Fanghui Li; Wentao Li; Qin Zhang; Yongli Gao; Wei Zhang; Zhi Zeng; Rui Zeng; Xiaoyang Liao; Qian Zhao; Zhi Wan
Journal:  BMC Geriatr       Date:  2022-04-12       Impact factor: 3.921

9.  Prevalence and determinants of frailty in the absence of disability among older population: a cross sectional study from rural communities in Nepal.

Authors:  Uday Narayan Yadav; Man Kumar Tamang; Tarka Bahadur Thapa; Hassan Hosseinzadeh; Mark Fort Harris; Krishna Kumar Yadav
Journal:  BMC Geriatr       Date:  2019-10-22       Impact factor: 3.921

10.  Longitudinal Association Between Physical Activity and Frailty Among Community-Dwelling Older Adults.

Authors:  Xuxi Zhang; Siok Swan Tan; Carmen Betsy Franse; Lovorka Bilajac; Tamara Alhambra-Borrás; Jorge Garcés-Ferrer; Arpana Verma; Greg Williams; Gary Clough; Elin Koppelaar; Tasos Rentoumis; Rob van Staveren; Antonius J J Voorham; Francesco Mattace-Raso; Amy van Grieken; Hein Raat
Journal:  J Am Geriatr Soc       Date:  2020-03-20       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.